Literature DB >> 15039360

Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease.

Claudio R F Marinho1, Daniella Z Bucci, Maria Lúcia Z Dagli, Karina R B Bastos, Marcos G Grisotto, Luiz R Sardinha, Cristiane R G M Baptista, Carlos Penha Gonçalves, Maria Regina D'Império Lima, José M Alvarez.   

Abstract

Chagas' disease is a chronic infection caused by Trypanosoma cruzi and represents an important public health burden in Latin America. Frequently the disease evolves undetectable for decades, while in a significant fraction of the affected individuals it culminates in death by heart failure. Here, we describe a novel murine model of the chronic infection with T. cruzi using a stable clone isolated from a human patient (Sylvio X10/4). The infection in the C3H/HePAS mouse strain progresses chronically and is mainly characterized by intense cardiac inflammatory lesions that recapitulate the chronic cardiac pathology observed in the human disease. Moderate striated muscle lesions are also present in C3H/HePAS mice. Viable parasites are detected and recovered from the chronic heart lesions of C3H/HePAS mice, supporting the current notion that development of heart pathology in Chagas' disease is related to parasite persistence in the inflamed tissue. By contrast, in infected A/J mice, chronic inflammatory lesions are targeted to the liver and the skeletal muscle, while pathology and parasites are undetectable in the heart. The phenotypic analysis of F(1) (A/J x C3H/HePAS) and F(2) (A/J x C3H/HePAS) mice suggests that the genetic predisposition to develop the inflammatory lesions caused by T. cruzi (Sylvio X10/4 clone) is heterogeneous because the heart and liver pathology segregate in the F(2) generation. These findings raise the hypothesis that the pathology heterogeneity observed in humans with Chagas' disease (absence and presence of cardiac or digestive chronic lesions) may be attributable to host genetic factors.

Entities:  

Mesh:

Year:  2004        PMID: 15039360      PMCID: PMC375186          DOI: 10.1128/IAI.72.4.2350-2357.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Pathogenesis of Chagas heart disease: role of autoimmunity.

Authors:  David M Engman; Juan S Leon
Journal:  Acta Trop       Date:  2002-02       Impact factor: 3.112

2.  Tissue tropism of different Trypanosoma cruzi strains.

Authors:  R C Melo; Z Brener
Journal:  J Parasitol       Date:  1978-06       Impact factor: 1.276

3.  Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens.

Authors:  Lain Pontes-de-Carvalho; Cláudia C Santana; Milena B P Soares; Geraldo G S Oliveira; Edecio Cunha-Neto; Ricardo Ribeiro-dos-Santos
Journal:  J Autoimmun       Date:  2002-03       Impact factor: 7.094

4.  A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi.

Authors:  R Ribeiro-Dos-Santos; J O Mengel; E Postol; R A Soares; E Ferreira-Fernandez; M B Soares; L C Pontes-De-Carvalho
Journal:  Parasite Immunol       Date:  2001-02       Impact factor: 2.280

Review 5.  Chemokines, inflammation and Trypanosoma cruzi infection.

Authors:  Mauro M Teixeira; Ricardo T Gazzinelli; João S Silva
Journal:  Trends Parasitol       Date:  2002-06

6.  Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection.

Authors:  S B Petkova; H B Tanowitz; H I Magazine; S M Factor; J Chan; R G Pestell; B Bouzahzah; S A Douglas; V Shtutin; S A Morris; E Tsang; L M Weiss; G J Christ; M Wittner; H Huang
Journal:  Cardiovasc Pathol       Date:  2000 Sep-Oct       Impact factor: 2.185

Review 7.  Parasite persistence in the aetiology of Chagas disease.

Authors:  R L Tarleton
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

8.  Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain.

Authors:  Sébastien Bagot; Susana Campino; Carlos Penha-Gonçalves; Sylviane Pied; Pierre-André Cazenave; Dan Holmberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

9.  Trypanosoma cruzi: immunological consequences of parasite modification of host cells.

Authors:  R Ribeiro Dos Santos; L Hudson
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

10.  Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.

Authors:  J Scharfstein; V Schmitz; V Morandi; M M Capella; A P Lima; A Morrot; L Juliano; W Müller-Esterl
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  20 in total

Review 1.  Molecular mechanisms of host cell invasion by Trypanosoma cruzi.

Authors:  Conrad L Epting; Bria M Coates; David M Engman
Journal:  Exp Parasitol       Date:  2010-06-18       Impact factor: 2.011

2.  Cavia porcellus as a model for experimental infection by Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Noelia Angulo; Manuela Verastegui; Daniel E Velásquez; Charles R Sterling; Diana Martin; Caryn Bern
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

3.  Oral infection of mice and host cell invasion by Trypanosoma cruzi strains from Mexico.

Authors:  Cecilia G Barbosa; César Gómez-Hernández; Karine Rezende-Oliveira; Marcos Vinicius Da Silva; João Paulo Ferreira Rodrigues; Monique G S Tiburcio; Thatiane Bragini Ferreira; Virmondes Rodrigues; Nobuko Yoshida; Luis E Ramirez
Journal:  Parasitol Res       Date:  2019-03-08       Impact factor: 2.289

4.  ECG detection of murine chagasic cardiomyopathy.

Authors:  Christopher S Eickhoff; Cade T Lawrence; John E Sagartz; Leesa A Bryant; Arthur J Labovitz; Simil S Gala; Daniel F Hoft
Journal:  J Parasitol       Date:  2010-08       Impact factor: 1.276

5.  Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.

Authors:  Christian Emerson Rosas-Jorquera; Luiz Roberto Sardinha; Fernando Delgado Pretel; André Luis Bombeiro; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

6.  Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection.

Authors:  Iryna Kurey; Tetyana Kobets; Helena Havelková; Martina Slapnicková; Lei Quan; Katerina Trtková; Igor Grekov; Milena Svobodová; Alphons P Stassen; Alan Hutson; Peter Demant; Marie Lipoldová
Journal:  Immunogenetics       Date:  2009-08-25       Impact factor: 2.846

7.  Bioluminescent imaging of Trypanosoma cruzi infection.

Authors:  Kenneth V Hyland; Sofya H Asfaw; Cheryl L Olson; Melvin D Daniels; David M Engman
Journal:  Int J Parasitol       Date:  2008-04-25       Impact factor: 3.981

8.  Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice.

Authors:  Antonio Morocoima; Grace Socorro; Régulo Avila; Ana Hernández; Solángel Merchán; Diana Ortiz; Gabriela Primavera; José Chique; Leidi Herrera; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2012-08-07       Impact factor: 2.289

9.  Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.

Authors:  Luiz Roberto Sardinha; Rosa Maria Elias; Tainá Mosca; Karina R B Bastos; Cláudio R F Marinho; Maria Regina D'Império Lima; José M Alvarez
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

10.  The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.

Authors:  Luiz Roberto Sardinha; Tainá Mosca; Rosa Maria Elias; Rogério Silva do Nascimento; Lígia A Gonçalves; Daniella Zanetti Bucci; Cláudio Romero Farias Marinho; Carlos Penha-Gonçalves; Maria Regina D'Império Lima; José Maria Alvarez
Journal:  PLoS Negl Trop Dis       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.